1. Introduction
===============

Cushing disease (CD) is a condition of pathologic hypercortisolism caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas. This ACTH-dependent hypercortisolemia would lead to devastating comorbidities including but not limited to cardiovascular disease, infections, and venous thrombosis, all of which make the overall mortality among patients with Cushing disease 1.7 to 4.8 times higher than that among healthy population.^\[[@R1]--[@R4]\]^ Currently, the 1st line therapy for Cushing disease is surgical excision of the pituitary adenomas.^\[[@R5]\]^ Based on results from long-term follow-up researches, patients who achieved remission criteria with 1 operation had better quality of life than the rest who needed 2nd-line therapies.^\[[@R4],[@R6]\]^ Furthermore, the size of adenoma, the extent of parasellar involvement, as well as the surgeon\'s technique, are key features in determining the clinical outcomes.^\[[@R7],[@R8]\]^ With transsphenoidal surgery, the reported remission rates among ACTH-secreting pituitary microadenomas range from 65% to 95%.^\[[@R3],[@R8]--[@R12]\]^ While macroadenomas have relatively lower remission rates of 12.5% to 71.1%, with more operative complications and higher recurrence rates.^\[[@R8],[@R9],[@R13]--[@R19]\]^ Cavernous sinus invasion is another unfavorable prognostic factor for transsphenoidal surgery.^\[[@R3]\]^ Specifically, the reported remission rates among ACTH-secreting pituitary adenomas with cavernous sinus invasion range from 0% to 60%.^\[[@R9],[@R12],[@R13],[@R19],[@R20]\]^ The surgical remission rates of Knosp grades 3 and 4 adenomas are lower, based on our comprehensive search of PubMed database.^\[[@R13],[@R19],[@R21]--[@R23]\]^

Here, we reported a case of Cushing disease caused by Knosp grade 4 ACTH-secreting pituitary adenoma. After thorough evaluation and transsphenoidal surgery, the patient was in remission. Subsequently, a systematic literature review of Knosp grades 3 and 4 ACTH-secreting pituitary adenomas was conducted. The clinical manifestations, surgical details, and postoperative recovery of these patients were discussed.

2. Case report
==============

A 33-year-old Asian woman had developed typical Cushingoid appearance, as well as amenorrhea and insomnia for 2 years. She had no visual loss or headache and denied history of glucocorticoid intake. On examination, her blood pressure was 159/107 mm Hg. She had a moon face with acne and hyperpigmentation, supraclavicular and dorsal fat pads, as well as central obesity (body mass index 23.9 kg/m^2^, waistline 82 cm). Systemic physical examination was otherwise unremarkable. Laboratory test results revealed a serum cortisol (8 [am]{.smallcaps}) level of 23.01 μg/dL (reference range 4--22.3 μg/dL), and a 24-hour urinary-free cortisol (24-hour UFC) value of 409.50 μg/24 h (reference range 12.3--103.5 μg). In addition, her serum ACTH level (8 [am]{.smallcaps}) was 100.60 pg/mL (reference range 0--46 pg/mL). She also had a slightly elevated serum prolactin (PRL) level of 34.31 ng/mL (reference range \<30 ng/mL). Her 24-hour UFC values were 101.25 μg/24 h after low-dose dexamethasone suppression test (LDDST) (reference range \<10 μg) and 264.81 μg/24 h after high-dose dexamethasone suppression test (HDDST) (reference range \<50% of baseline level). All other anterior pituitary hormones were within the normal range. Magnetic resonance imaging (MRI) with gadolinium enhancement (Fig. [1](#F1){ref-type="fig"}) showed a heterogeneously enhanced mass (2.0 × 2.5 × 1.8 cm^3^ in size) in the sella turcica and suprasellar space. The mass had invaded the right cavernous sinus and encased the right internal carotid artery (ICA) completely (Knosp grade 4). We also arranged computed tomography scans of chest and abdomen, as well as somastatin receptor scintigraphy, none of which had abnormal findings. The patient was diagnosed with Cushing disease despite her impaired response to HDDST, due to the reported observations that high-dose dexamethasone induced ACTH suppressibility was lost in some ACTH-secreting macroadenomas.^\[[@R15],[@R17],[@R24]\]^ Besides, all the comorbidities including hypertension, diabetes mellitus, and hyperlipemia were treated accordingly before her surgery.

![Preoperative magnetic resonance imaging. (A) Saggital postcontrast T1-weighted, (B) coronal postcontrast T1-weighted, and (C) coronal T2-weighted MRI show a Knosp grade 4 pituitary macroadenoma which extends from the sella turcica into the suprasellar space.](medi-97-e13148-g001){#F1}

Endoscopic endonasal transsphenoidal surgery was conducted, with intraoperative endonasal transsphenoidal Doppler and image-guidance devices to locate the tumor precisely and avoid damaging the ICA. The tumor tissue was grayish white in appearance, and abundant in blood supply. The texture was soft and fragile, with no pseudocapsule. The intrasellar and suprasellar part of the lesion was the 1st to be removed, then was the compressed pituitary tissue with abnormal appearance. Finally, the tumor tissue around right ICA was resected through the defect on the medial wall of cavernous sinus, with the location of ICA confirmed by transsphenoidal Doppler and image guidance. The total size of resected tumor tissue added up to around 20 × 25 × 15 mm^3^. Subsequent saline irrigation confirmed no residual tumor tissue in the surgical field. The diaphragm descended into the pituitary fossa after tumor removal, and no cerebrospinal fluid leakage was noted during the procedure.

After surgery, the resected tumor specimen was processed for hematoxylin and eosin staining and immunohistochemistry staining (Fig. [2](#F2){ref-type="fig"}) in the pathology department of our institution. Results of histopathologic examination confirmed our preoperative diagnosis of ACTH-secreting pituitary adenoma. And the immunohistochemistry staining results were as follows: ACTH (+), growth hormone (GH) (+), follicle-stimulating hormone (±), PRL (−), luteinizing hormone (LH) (−), thyroid-stimulating hormone (−), P53 (−), and Ki-67 (index 1%).

![Postoperative pathologic stainings of the resected pituitary tumor, with (A) hematoxylin eosin, (B) anti-adrenocorticotropic hormone antibody. The original magnification of these pictures was 200 times.](medi-97-e13148-g002){#F2}

The patient\'s postoperative course was rather smooth, despite transient diabetes insipidus in the 1st 12 hours. Lab results confirmed that she was in remission.^\[[@R5]\]^ Her postoperative morning serum cortisol level was 4.97 μg/dL on day 1 (8 [am]{.smallcaps}), then dropped to 1.60 μg/dL on day 2 (8 [am]{.smallcaps}). She experienced symptoms of secondary adrenal insufficiency including mild headache and nausea on postoperative day 2, and temporary hydrocortisone replacement was prescribed. In addition, her daily ACTH levels (8 [am]{.smallcaps}) were 17.4, 13.3, and 7.7 pg/mL on the first 3 days after surgery. On postoperative day 3, her blood pressure maintained in the range of 110 to 120/70 to 80 mm Hg without medication. Postoperative MRI (Fig. [3](#F3){ref-type="fig"}) revealed gross-total resection of the Knosp grade 4 macroadenoma. She was discharged 3 days after the surgery. As of this report, the patient was 1 year into her recovery. During her last follow-up, she had a serum cortisol (8 [am]{.smallcaps}) level of 5.49 μg/dL and ACTH level of 16.1 pg/mL. Informed written consent was obtained from the patient for publication of this case report and accompanying images.

![Postoperative magnetic resonance imaging (MRI). No residul tumor is found on the (A) saggital postcontrast T1-weighted, as well as the coronal (B) postcontrast T1-weighted and (C) T2-weighted MRI.](medi-97-e13148-g003){#F3}

3. Discussion
=============

In Cushing disease, patients with cavernous sinus invasion had lower biochemical remission rates after transsphenoidal surgery, comparing to those with noninvasive pituitary adenomas.^\[[@R7],[@R8]\]^

To evaluate the surgical outcomes of ACTH-secreting pituitary adenomas, especially those with Knosp grades 3 and 4 cavernous sinus invasion, we conducted a systematic literature search.

As shown in Figure [4](#F4){ref-type="fig"}, PubMed database was searched for relevant literature, with strings including (("Cushing disease") AND ("cavernous sinus invasion")), (("Cushing disease") AND ("knosp")), (("pituitary ACTH adenoma") AND ("cavernous sinus invasion")) and (("pituitary ACTH adenoma") AND ("knosp")). A total of 68 articles were generated from the PubMed search, and 4 outside of the search. Then the abstracts were used to determine whether the surgical outcomes of Cushing disease were the focus. Forty-one articles were excluded, and full texts of the rest were used to determine inclusion or exclusion. The inclusion criteria for analysis were functional ACTH-secreting adenoma, Knosp grades 3 and 4, surgery for the 1st time, surgical outcomes reported in the article. While the exclusion criteria were non-English language articles, incorrect tumor type, Knosp grades 0 to 2 adenoma, clinical outcomes not mentioned or incomplete. Full text screening generated 5 articles that fit the criteria, and all of them are listed in Table [1](#T1){ref-type="table"}.^\[[@R13],[@R19],[@R21]--[@R23]\]^

![This PRISMA diagram shows the method we used in the PubMed literature search.](medi-97-e13148-g004){#F4}

###### 

Literature review: clinical outcomes after initial surgery for Knosp grades 3 and 4 adrenocorticotropic hormone-secreting pituitary adenomas.

![](medi-97-e13148-g005)

In these studies, surgeries were performed with the universal endonasal transsphenoidal approach. In the cohort reported by Shin et al,^\[[@R23]\]^ 6 patients suffered from Knosp grades 3 and 4 ACTH-secreting pituitary adenoma, and 3 achieved the biochemical remission criteria adopted by the authors. Wagenmakers et al^\[[@R19]\]^ reported biochemical remission of 1 patient with Knosp grade 4 adenoma, and 3 with Knosp grade 3 adenoma. Kuo et al^\[[@R22]\]^ also reported a total of 5 patients with Knosp grade 4 adenoma, and postsurgery 2 patients were in remission. However, none of the patients with Knosp grades 3 and 4 adenoma were in remission after surgery, according to the case series from Witek et al.^\[[@R13]\]^. In the meantime, Ceylan et al^\[[@R21]\]^ provided 2 patients with Knosp grade 4 adenoma and 2 with Knosp grade 3 adenoma. 3 of Ceylan\'s patients were in remission.

To conclude, 36 patients with Knosp grades 3 and 4 ACTH-secreting pituitary adenoma had been reported, and 12 achieved the remission criteria adopted by the original articles after their 1st surgery. However, those remission criteria were different. Specifically, Witek et al^\[[@R13]\]^ and Wagenmakers et al^\[[@R19]\]^ adopted stricter criteria, in comparison to the current Cushing disease guideline recommended criteria, that is, morning serum cortisol levels \<5 μg/dL or 24-hour UFC value of 10 to 20 μg/24 h in the first 7 days postoperation.^\[[@R5]\]^ Whereas the criteria used by Ceylan et al^\[[@R21]\]^ were less strict. While in our case, the patient\'s surgical outcome was evaluated with the criteria recommended by the current guideline.^\[[@R5]\]^ The difference in adopted remission criteria might affect the conclusions of some patients' clinical outcomes. However, these articles did not include the original postoperative lab results, which made the re-evaluation of each patient\'s postoperative endocrinal state with the current guideline recommended criteria unfeasible.

Our case, along with the results from the systematic literature review, suggested that Cushing disease caused by Knosp grade 4 pituitary adenoma can be successfully controlled with 1 operation. Furthermore, a multidisciplinary team would advance the clinical management of Cushing disease. Clinicians should continue to investigate and report new cases, for better understanding of this condition.
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